-
India's GDP for 2020-21 contracted by 7.3%, even as GDP for the year's last quarter (January-March 2021) grew by 1.6%, official data released by the National Statistical Office showed on May 31.
-
Here are top money making ideas from technical analysts that may deliver good gains in the near term.
-
All eyes will be on how the Nifty will react to the GDP numbers. India has clocked in a negative growth of 7.3% for 2020-21 while for Q4FY21, economy has grown by 1.6%
-
Starting June 1st, 2021, traders are expected to have 75% of the peak margin available with the broker i.e. intraday leverage provided for Equity Cash and F&O Intraday would be 1.33X going forward
-
The investor sentiment was further boosted as daily fresh Covid caseload dropped to the lowest daily in 50 days with 1,52,734 cases
-
Antique Stock Broking said: "Our analysis suggests that macro green shoots are visible in globally linked sectors like metals and IT services."
-
Aurobindo Pharma's consolidated revenue from operations stood at Rs 6,001.50 crore for the quarter under consideration. It was Rs 6,158.43 crore a year ago
-
Divis Laboratories' board of directors has proposed a dividend of Rs 20 per share of face value Rs 2 each for the financial year 2020-21
-
The scrip jumped 20% to Rs 525.20 in the morning trade, while the benchmark BSE Sensex traded over 400 points higher at around 51,800
-
Shares of the company have soared 707% to Rs 57.90 on May 28, 2021 from Rs 7.17 on May 28 last year